1.
Efficacy of Bevacizumab to Reduce Lid Margin Vascularity and Alteration in Tear Film Status. Annals KEMU [Internet]. 2021 Nov. 4 [cited 2024 Mar. 29];27(Special Issue (Jul-Sep):368-71. Available from: https://www.annalskemu.org/journal/index.php/annals/article/view/4656